A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects
Status:
Completed
Trial end date:
2014-01-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of the study drug
(DX-2930) administered subcutaneously in healthy subjects. Subjects will be randomized to
receive DX-2930 or placebo.